Dawn Svoronos is Director of Global Blood Therapeutics, Inc.. Currently has a direct ownership of 0 shares of GBT, which is worth approximately $0. The most recent transaction as insider was on Oct 05, 2022, when has been sold 5,376 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Dawn Svoronos Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 05 2022
SELL
Sale (or disposition) back to the issuer
-
5,376 Reduced 100.0%
0 Common Stock
Jun 21 2022
SELL
Open market or private sale
$51,974 $27.24 p/Share
1,908 Reduced 26.19%
5,376 Common Stock
Jun 14 2022
BUY
Exercise of conversion of derivative security
-
3,600 Added 33.08%
7,284 Common Stock
Jun 18 2021
SELL
Open market or private sale
$58,793 $36.54 p/Share
1,609 Reduced 30.4%
3,684 Common Stock
Jun 17 2021
BUY
Exercise of conversion of derivative security
-
3,037 Added 36.46%
5,293 Common Stock

Also insider at

ADVM
Adverum Biotechnologies, Inc. Healthcare
PTCT
PTC THERAPEUTICS, INC. Healthcare
XENE
Xenon Pharmaceuticals Inc. Healthcare
SLRN
ACELYRIN, Inc.
DS

Dawn Svoronos

Director
South Plainfield, NJ

Track Institutional and Insider Activities on GBT

Follow Global Blood Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GBT shares.

Notify only if

Insider Trading

Get notified when an Global Blood Therapeutics, Inc. insider buys or sells GBT shares.

Notify only if

News

Receive news related to Global Blood Therapeutics, Inc.

Track Activities on GBT